Maria K. Storch
Medical University of Graz
62 Papers
578 Citations
Maria K. Storch is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Experimental autoimmune encephalomyelitis & Multiple sclerosis. The author has an hindex of 37, co-authored 61 publications. Previous affiliations of Maria K. Storch include Medical University of Vienna & Max Planck Society.
Chat about Author
Papers
Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures.
S. Pouly,Maria K. Storch,Jean-Marie Matthieu,Hans Lassmann,Florianne Monnet-Tschudi,Paul Honegger +5 more
TL;DR: The present results suggest that PKC activation resulted in severe demyelination and partial loss of the oligodendrocyte‐differentiated phenotype.
17
MHC Class II Isotype- and Allele-Specific Attenuation of Experimental Autoimmune Encephalomyelitis
Katrien L. de Graaf,Silvia Barth,Martin Herrmann,Maria K. Storch,Christoph Otto,Tomas Olsson,Arthur Melms,Günther Jung,Karl-Heinz Wiesmüller,Robert Weissert +9 more
TL;DR: A rational design of strong M HC class II-binding peptides with absolute isotype and allele specificity able to compete for autoantigenic sequences presented on disease-associated MHC class II molecules is demonstrated.
16
Relapsing acute transverse myelitis: a specific entity.
TL;DR: Relapsing ATM not related to systemic disease appears to be a specific entity which accounts for severe disability and currently lacks effective treatment.
16
Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.
Thomas Seifert-Held,Thomas Pekar,Thomas Pekar,Thomas Gattringer,Nicole E. Simmet,Hubert Scharnagl,Christoph Bocksrucker,Christian Lampl,Maria K. Storch,Tatjana Stojakovic,Franz Fazekas +10 more
TL;DR: Plasma MR-proADM levels improve prediction of functional outcome in ischemic stroke when added to the patients' age, NIHSS on admission, and the use of recanalization therapy.
Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
Katrien L. de Graaf,Silvia Barth,Martin M. Herrmann,Maria K. Storch,Karl-Heinz Wiesmüller,Robert Weissert +5 more
TL;DR: The data demonstrate that the most critical factor in inducing MS like pathology is presentation of autoantigenic peptides on MHC class II molecules resulting in demyelination and axonal pathology.
14